Prioritizing Parental Worry Associated with Duchenne Muscular Dystrophy Using Best-Worst Scaling

Holly Landrum Peay1,2, I L Hollin3, J F P Bridges3

  • 1Parent Project Muscular Dystrophy, 401 Hackensack Ave 9th Floor, Hackensack, NJ, 07601, USA. holly@parentprojectmd.org.

Insights

Parents of children with Duchenne muscular dystrophy (DMD) prioritize worries about weakness progression and care access. Interventions should address the emotional toll of caring for a child with this progressive, fatal disease.

Area of Science:

  • Pediatric rare diseases
  • Clinical psychology
  • Patient-reported outcomes

Background:

  • Duchenne muscular dystrophy (DMD) is a severe pediatric disorder impacting families.
  • Understanding parental concerns is crucial for effective clinical support.
  • Existing assessment methods may not fully capture parental priorities.

Purpose of the Study:

  • To identify and prioritize parental worries related to Duchenne muscular dystrophy.
  • To compare these priorities between parents of ambulatory and non-ambulatory children.
  • To demonstrate the utility of Best-Worst Scaling (BWS) in assessing parental concerns.

Main Methods:

  • A community-engaged approach identified 16 short-term worries in DMD.
  • Best-Worst Scaling (BWS) was employed with 119 parents to rank worries.
  • Independent-sample t-tests analyzed differences based on child's ambulatory status.

Main Results:

  • The highest parental priorities were weakness progression and consistent care access.
  • Parents of ambulatory children prioritized avoiding missed treatments and parental adequacy more than those with non-ambulatory children.
  • Parents of non-ambulatory children were more concerned about their child feeling like a burden.

Conclusions:

  • Caregiver interventions must address the emotional burden of DMD, irrespective of disease stage.
  • BWS provides a clinically relevant and accessible method for prioritizing patient and caregiver concerns.
  • This approach offers an alternative to traditional rating scales for assessing disease impact.

Related Concept Videos